Annual Total Long Term Liabilities
$6.76 M
+$2.81 M+70.99%
December 31, 2023
Summary
- As of February 7, 2025, YMAB annual total long term liabilities is $6.76 million, with the most recent change of +$2.81 million (+70.99%) on December 31, 2023.
- During the last 3 years, YMAB annual total long term liabilities has risen by +$80.00 thousand (+1.20%).
- YMAB annual total long term liabilities is now at all-time high.
Performance
YMAB Long Term Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Long Term Liabilities
$3.20 M
-$2.03 M-38.88%
September 30, 2024
Summary
- As of February 7, 2025, YMAB quarterly total long term liabilities is $3.20 million, with the most recent change of -$2.03 million (-38.88%) on September 30, 2024.
- Over the past year, YMAB quarterly long term liabilities has dropped by -$3.56 million (-52.69%).
- YMAB quarterly long term liabilities is now -53.83% below its all-time high of $6.92 million, reached on September 30, 2023.
Performance
YMAB Quarterly Long Term Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Long Term Liabilities Formula
Long-Term Liabilities = Long-Term Debt + Deferred Tax Liabilities + Pension Liabilities + Other Long-Term Liabilities
YMAB Long Term Liabilities Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +71.0% | -52.7% |
| 3 y3 years | +1.2% | -19.1% |
| 5 y5 years | +197.1% | -19.1% |
YMAB Long Term Liabilities Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | +71.0% | -53.8% | at low |
| 5 y | 5-year | at high | +74.3% | -53.8% | at low |
| alltime | all time | at high | +229.6% | -53.8% | +55.9% |
Y-mAbs Therapeutics Long Term Liabilities History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $3.20 M(-38.9%) |
| Jun 2024 | - | $5.23 M(-19.8%) |
| Mar 2024 | - | $6.52 M(-3.5%) |
| Dec 2023 | $6.76 M(+71.0%) | $6.76 M(-2.4%) |
| Sep 2023 | - | $6.92 M(+98.8%) |
| Jun 2023 | - | $3.48 M(-5.8%) |
| Mar 2023 | - | $3.70 M(-6.5%) |
| Dec 2022 | $3.95 M(-17.7%) | $3.95 M(-1.3%) |
| Sep 2022 | - | $4.00 M(-7.6%) |
| Jun 2022 | - | $4.33 M(-4.4%) |
| Mar 2022 | - | $4.53 M(-5.6%) |
| Dec 2021 | $4.80 M | $4.80 M(+27.2%) |
| Sep 2021 | - | $3.77 M(-9.6%) |
| Jun 2021 | - | $4.18 M(-26.7%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2021 | - | $5.70 M(-14.6%) |
| Dec 2020 | $6.68 M(+72.2%) | $6.68 M(-3.3%) |
| Sep 2020 | - | $6.91 M(+23.0%) |
| Jun 2020 | - | $5.61 M(+43.9%) |
| Mar 2020 | - | $3.90 M(+0.6%) |
| Dec 2019 | $3.88 M(+70.5%) | $3.88 M(+3.3%) |
| Sep 2019 | - | $3.75 M(-6.9%) |
| Jun 2019 | - | $4.03 M(-3.7%) |
| Mar 2019 | - | $4.18 M(+83.9%) |
| Dec 2018 | $2.27 M(+10.9%) | $2.27 M(+10.9%) |
| Sep 2018 | - | $2.05 M(0.0%) |
| Jun 2018 | - | $2.05 M(0.0%) |
| Dec 2017 | $2.05 M(-7.9%) | $2.05 M |
| Dec 2016 | $2.23 M | - |
FAQ
- What is Y-mAbs Therapeutics annual total long term liabilities?
- What is the all time high annual total long term liabilities for Y-mAbs Therapeutics?
- What is Y-mAbs Therapeutics annual total long term liabilities year-on-year change?
- What is Y-mAbs Therapeutics quarterly total long term liabilities?
- What is the all time high quarterly long term liabilities for Y-mAbs Therapeutics?
- What is Y-mAbs Therapeutics quarterly long term liabilities year-on-year change?
What is Y-mAbs Therapeutics annual total long term liabilities?
The current annual total long term liabilities of YMAB is $6.76 M
What is the all time high annual total long term liabilities for Y-mAbs Therapeutics?
Y-mAbs Therapeutics all-time high annual total long term liabilities is $6.76 M
What is Y-mAbs Therapeutics annual total long term liabilities year-on-year change?
Over the past year, YMAB annual total long term liabilities has changed by +$2.81 M (+70.99%)
What is Y-mAbs Therapeutics quarterly total long term liabilities?
The current quarterly long term liabilities of YMAB is $3.20 M
What is the all time high quarterly long term liabilities for Y-mAbs Therapeutics?
Y-mAbs Therapeutics all-time high quarterly total long term liabilities is $6.92 M
What is Y-mAbs Therapeutics quarterly long term liabilities year-on-year change?
Over the past year, YMAB quarterly total long term liabilities has changed by -$3.56 M (-52.69%)